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a b s t r a c t
Corynebacterium striatum (C. striatum) is a ubiquitous saprophyte with a potential to cause
bacteremia. We report the ﬁrst case of C. striatum endocarditis in a patient with congenital
lymphedema and rheumatic heart disease.
# 2015 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Endocarditis1. IntroductionCorynebacterium species are aerobic, non-sporulating, gram
positive bacilli that are often considered as non-pathogenic* Corresponding author.
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http://dx.doi.org/10.1016/j.ihj.2015.07.026
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).components of normal skin ﬂora and mucosal membranes.
Although frequently isolated in cultures, they are commonly
considered as contaminants. Nevertheless, the ability of these
bacteria to cause life-threatening disease is well established,
and over the last decade, there have been increasing reports ofB.V. This is an open access article under the CC BY-NC-ND license
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including bacteremia and endocarditis. Corynebacterium spe-
cies are now thought to cause 9% of early and 4% of late
prosthetic valve endocarditis, but only 0.2–0.4% of cases of
native valve endocarditis. Recognized risk factors for Coryne-
bacterium endocarditis include preexisting cardiac disease, a
prior history of bacterial endocarditis, and the presence of
prosthetic devices, including intravascular access and aur-
iculo-ventricular cerebrospinal ﬂuid shunts.
Corynebacterium striatum (C. striatum) has been increasingly
reported as the etiologic agent of various infections.1 Blood
cultures positive for Corynebacterium species and C. striatum in
particular should never be overlooked.2
2. Case reportFig. 1 – 2D ECHO revealing mitral valve prolapse with
moderate mitral regurgitation with evidence of vegetation
on the anterior mitral valve leaflet.We report a ﬁrst case of rheumatic heart disease complicated
with infective endocarditis due to C. striatum. A 27-year-old
male, who was a known case of rheumatic heart disease,
presented with history of fever of 15 days duration. Also, he
gave history of partial seizures involving left upper limb and
face of 7 days duration. He had past history of swelling of both
lower limbs up to knee since birth. On clinical examination,
the patient had temperature of 99 8F or 37.2 8C, normal vital
signs, no evidence of pallor, clubbing, or lymphadenopathy. He
had bilateral lower limb induration and edema up to knees.
Cardiovascular examination revealed a pansystolicmurmur at
the apex radiating to axilla. Lab ﬁndings revealed Hb 12.6 g/dl,
WBC 14,500 cells/mm3, 83.5% neutrophils, 11.7% lymphocytes,
and Erythrocyte Sedimentation Rate 36 mm/h. The other
biochemical parameters were within normal limits. 2D
echocardiography revealed mitral valve prolapse with moder-
ate mitral regurgitation and evidence of vegetation on the
anterior mitral valve leaﬂet (Fig. 1). CT brain was done to ﬁnd
the cause of seizure, which was normal. The patient was
empirically started with IV crystalline penicillin 20 lakh units
4th hourly and gentamicin 80 mg bd; later, the antibiotic was
changed to IV cefuroxime 2 g iv bd based on the culture
sensitivity report. The patient responded clinically to anti-
biotics and was asymptomatic after one week of antibiotics.
Repeat echocardiography showed decrease in the size of
vegetation. The patient was discharged and advised a regular
follow-up.
3. Microbiological identiﬁcationBlood cultures were performed using BacT/Alert system. Two
of the three samples gave positive signal for growth. Gram
staining revealed Gram-positive short bacilli. Subcultures
were performed on sheep blood agar and MacConkeys agar
and incubated at 37 8C.
Blood agar was incubated in CO2 incubator. Moist white
colored colonieswere observed in 48 h, Gramstaining revealed
short Gram-positive bacilli. Identiﬁcation of the isolate as C.
striatum was based on colony morphology, Gram staining,
motility, the catalase, and oxidase reactions, and the results
obtained was conﬁrmed by use of the VITEK 2 Compact 2
system (BioMèrieux, l'Etoile, France) as C. striatum.Antibiotic susceptibility was tested by the disk diffusion
method in Mueller-Hinton agar supplemented with 5% blood.
The isolate was susceptible to cefazolin (30 mcg), cefuroxime
(30 mcg), linezolid (30 mcg), vancomycin (30 mcg), teicoplanin
(30 mcg), cefotaxime (30 mcg) and ceftriaxone (30 mcg). The
isolate was resistant to penicillin G 10 units, erythromycin
(15 mcg), azithromycin (15 mcg), levoﬂoxacin (5 mcg), and
ciproﬂoxacin (5 mcg).
There is neither a recognized standard method nor speciﬁc
guidelines published by Clinical Laboratory Standards Insti-
tute (CLSI) for antimicrobial testing of coryneform bacteria.2
Hence, the susceptibility criteria of the CLSI for Staphylococcus
spp. were used for all antibiotics tested except penicillin and
ampicillin, for which thresholds for Listeria spp. were used.
4. DiscussionC. striatum is a part of the normal ﬂora of the human skin and
respiratory tract. Although rare, non-diphtheriae corynebac-
teria have known to cause endocarditis in individuals with
predisposing risk factors such as prior cardiac disease, drug
injection, indwelling prosthetic devices, or chronic hemodial-
ysis, and only few cases involving C. striatum associated
endocarditis, including native valve prosthetic valve and
pacemaker-related endocarditis, are well being documen-
ted.1–5 For many years, Corynebacterium species was long
believed to have limited potential as a pathogen, and hence
was usually considered a contaminant when isolated from a
patient specimen. Evidence to support the role of C. striatum as
a pathogen in immunocompromised and immunocompetent
hosts is growing. Edward et al. have reported a case of C.
striatum cutaneous infection in a patient with AIDS.3 The role
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et al. have reported a case of spontaneous joint infection with
C. striatum.4 Olivia et al. have reported cardiac device related
infection by C. striatum.8
Our patient was diagnosed with congenital lymphedema.
Literature search on congenital lymphedema implies that in
long-standing cases of lymphedema, the skin becomes scaly
and cracked, and is prone for secondary bacterial or fungal
infections (ref New York Health Care – lymphedema). In our
case, the most likely route of entry/access of C. striatumwould
have been through minute abrasions on the skin. Gandham
et al. have reported a case of necrotizing fasciitis of lower limb
by C. striatum in a HBsAG positive patient, indicating deep
seated infection secondary to trauma, which could have
provided the portal of entry for C. striatum.7 Superti et al. have
reported a case of C. striatum skin and soft tissue infection of a
malignant skin lesion.7 Martin et al. isolated identical strains
of C. striatum from a leg ulcer and from the blood stream in a
patient with peripheral vascular disease, conﬁrming the entry
of the bacterium through the skin to the circulation.2
C. striatum, a normal skin commensal, is rarely isolated in
native valve endocarditis and most often requires surgical
management with appropriate antibiotics1; however, our
patient recovered with medical management with injection
of cefuroxime for six weeks. Blood cultures at the end of
antibiotic treatment remained negative. The patient was
asymptomatic at follow-up after one and three months.
The antibiotic susceptibility pattern of C. striatum is
variable. Among strains of C. striatum, multidrug resistance
may be spreading. A decade ago, isolates showed sensitivity to
beta lactams (particularly penicillin G), ﬂuoroquinolones,
carbapenems, linezolid, and vancomycin.4 In the last 5 years,
pathogenic isolates showing multidrug resistance have
emerged.4 Signiﬁcant number of authors have used vancomy-
cin as initial therapy for suspected infection.2–6
5. ConclusionsC. striatum is a potentially pathogenic microorganismwith the
ability to produce infection like infective endocarditis in a
native valve, which should never be ignored as a contaminant.
It is a potential cause for infection in patients with establishedrisk factors like rheumatic heart disease. C. striatum infections
should be treated according to the results of the antibiogram,
as it is an emerging multidrug-resistant organism. Universal
hygiene measures should be observed, as this potentially
infectious organism is able to cause nosocomial infections and
colonization.
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